Related Research Articles
Essential hypertension is a form of hypertension without an identifiable physiologic cause. It is the most common type affecting 85% of those with high blood pressure. The remaining 15% is accounted for by various causes of secondary hypertension. Essential hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Hypertension can increase the risk of cerebral, cardiac, and renal events.
The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.
Melvyn Rubenfire is a cardiologist in the University of Michigan Health System, as well as a professor in the department of internal medicine. He is also director of the preventive cardiology department.
The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease. In 2008, it became the country's first medical research institute to target diabetes, heart disease, obesity and their complications at the basic, clinical and population health levels.
Stephen William MacMahon AO DSc FAA FMediSci FAHMS FACC is a British-Australian academic medical researcher, healthcare entrepreneur and founder of The George Institute for Global Health. He holds professorial academic appointments in medicine at UNSW Sydney and Imperial College London.
The Heart Research Institute (HRI) is a not-for-profit research facility, originally based in Camperdown, New South Wales, Australia and currently based in Newtown, New South Wales.
Jason X.-J. Yuan is an American physician scientist whose research interests center on pulmonary vascular pathobiology and pulmonary hypertension. His current research is primarily focused on the pathogenic mechanisms of pulmonary vascular diseases and right heart failure.
Dr Eugen Molodysky OAM, MMBS is an academic and medical practitioner in preventive medicine and translational research. His research has been published in peer reviewed journals over the last 30 years. His clinical work has contributed to the early identification of HIV/AIDS in the 1980s epidemic in Australia.
Norman R.C. Campbell is a Professor Emeritus of the University of Calgary, where he served as professor of Medicine, Community Health Sciences and Physiology and Pharmacology and as a member of the O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta. Dr Campbell continues as a Senior consultant to Resolve To Save Lives (RTSL), a temporary advisor to the World Bank to provide advice for hypertension control in Samoa and Cambodia, a consultant to the Pan American Health Organization Hearts in the Americas Initiative and a consultant to the for hypertension control in Mongolia.
Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.
Suzanne Oparil is a clinical cardiologist and Distinguished Professor of Medicine, Professor of Cell, Developmental, and Integrative Biology. She is the Section Chief of Vascular Biology and Hypertension and the Director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Disease at the University of Alabama-Birmingham (UAB) Medical School.
Professor David Wayne Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.
Ricardo Luis Armentano Feijoo is an Uruguayan professor and researcher who has worked in biomedical engineering and cardiovascular systems. He currently serves as the director of the GIBIO research group at the National Technological University — Buenos Aires Regional Faculty (Argentina). Also he is the director of the Department of Biological Engineering, University of the Republic (Uruguay). He has two doctoral degrees, two post-doctoral degrees, and has authored more than 300 research articles and 20 books/book chapters.
Harriet Pearson Dustan (1920–1999) was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.
John Philip Chalmers is an Australian medical researcher, best known for his work in the field of cardiovascular physiology, specifically for his research into hypertension.
Jason C. Kovacic is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York.
Anne Monique Nuyt is a Canadian paediatrician who is Professor of Neonatology and Canada Research Chair in Prematurity and Developmental Origins of Cardiovascular Health and Diseases at the Université de Montréal. Her research considers how perinatal oxidative stress can alter the structural development and function of the cardiovascular system.
Gemma Alexandra Figtree is an Interventional Cardiologist at Royal North Shore Hospital, Professor in Medicine at the University of Sydney, chair of the Federal Government's 10-year Mission for Cardiovascular Health, and co-leader of the Cardiovascular Theme for Sydney Health Partners.
Sanjay Rajagopalan is the Herman Hellerstein Professor of Medicine and Chief Scientific and Medical Officer at the Harrington Heart and Vascular Institute, University Hospitals and Professor Medicine at Case Western Reserve University (CWRU) in Cleveland, Ohio. He holds secondary appointments in the Case Western Reserve University Departments of Physiology, Radiology and Biomedical Engineering. Much of his research has been on using technology to guide the detection and treatment of heart disease and more recently on the impact of environmental exposures and climate change on cardiovascular health.
Lionel Henry Opie was a South African cardiologist. He was a professor of medicine at the University of Cape Town, where he conducted both experimental and clinical research on heart disease and cardiovascular physiology, metabolism, and pharmacology. He was the founding director of the university's Hatter Institute for Cardiovascular Research and the founding editor of the Journal of Molecular and Cellular Cardiology. He also served as president of the International Society for Heart Research.
References
- ↑ "Professor Alta Schutte". University of New South Wales . Retrieved 13 September 2021.
- ↑ "These powerful African scientists are changing the world". One. 9 February 2018. Retrieved 13 September 2021.
- ↑ "Professor Alta Schutte". The George Institute. Retrieved 13 September 2021.
- ↑ "George Clinical Scientific Leadership Adds Hypertension and CV Researcher Prof Alta Schutte". Cardiology2. 21 August 2020. Archived from the original on 13 September 2021. Retrieved 13 September 2021.
- ↑ "Alta Schutte, PhD – George Clinical" . Retrieved 28 February 2022.
- ↑ "We delve deep into the data to reveal excellence" . Retrieved 15 November 2023.
- ↑ "UNSW Academic Honoured in Annual NHMRC research awards" . Retrieved 4 April 2024.
